Palumbo Pierpaolo, Cannizzaro Ester, Palumbo Maria Michela, Di Cesare Annamaria, Bruno Federico, Acanfora Chiara, Arceri Antonella, Evangelista Laura, Arrigoni Francesco, Grassi Francesca, Grassi Roberta, Pradella Silvia, Miele Vittorio, Giovagnoni Andrea, Splendiani Alessandra, Barile Antonio, Masciocchi Carlo, Di Cesare Ernesto
Department of Diagnostic Imaging, Area of Cardiovascular and Interventional Imaging, Abruzzo Health Unit 1, Via Saragat, Località Campo di Pile, 67100 L'Aquila, Italy.
SIRM Foundation, Italian Society of Medical and Interventional Radiology (SIRM), 20122 Milan, Italy.
Diagnostics (Basel). 2022 Sep 23;12(10):2298. doi: 10.3390/diagnostics12102298.
Since 1997, heart failure (HF) has been designated as a new epidemic. However, it is not easy to find a proper definition since different descriptors are used in clinical practice. Moreover, HF is not a single clinical entity, and there is a close relationship between HF and all cardiomyopathies (CMs). This leads us to also consider accuracy in the characterization of CMs, which is essential to define the therapeutic process of HF patients. This narrative review aims to describe the main mechanisms leading to HF in different CMs, as well as the current diagnostic and prognostic advantages deriving from advanced imaging in the cardiac field.
自1997年以来,心力衰竭(HF)被认定为一种新的流行病。然而,由于临床实践中使用了不同的描述词,因此很难找到一个恰当的定义。此外,HF并非单一的临床实体,并且HF与所有心肌病(CM)之间存在密切关系。这也促使我们去考虑CM特征描述的准确性,而这对于确定HF患者的治疗过程至关重要。本叙述性综述旨在描述不同CM中导致HF的主要机制,以及心脏领域先进成像技术目前在诊断和预后方面的优势。